AMARILLO, TX (US), October 2021 — Several studies conducted over the last decade have concluded that dry eye disease (DED) affects up to 50 percent of the U.S. population, creating a liability for the nation’s health care system that is estimated to exceed $50 billion annually.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
SINGAPORE, October 2021 — Inherited retinal diseases (IRDs) are a group of genetically and clinically homogeneous illnesses characterized by progressive retinal damage leading to vision loss. The global incidence of IRDs is approximately one in 2,000 persons.
ATHENS, GA (US), October 2021 — With global rates of male infertility continuing to rise, a new study in spermatogonial stem cell research led by researchers at the University of Georgia provides hope for future clinical therapies.
VIENNA (AT), October 2021 — More than 40,000 allogeneic hematopoietic stem cell transplants are carried out worldwide every year, mostly for patients suffering from leukemia or other diseases of the hematopoietic system.
AARHUS (DK), October 2021 — A new study from Aarhus University delivers a significant advancement in stem cell research and the opportunities for treating patients with a new cell-based immunotherapy.
LOS ANGELES, CA (US), October 2021 — Lizards can regrow severed tails, making them the closest relative to humans that can regenerate a lost appendage.
TOKYO (JP), October 2021 – Although sometimes hard to accept, with aging many things in our bodies change. One of these is the ability of the skin to regenerate. Old skin is just not as good as young skin at healing wounds.
BARCELONA (ES), October 2021 — Muscle is known to regenerate through a complex process that involves several steps and relies on stem cells.
DALLAS, TX (US), October 2021 — Specialized cells that conduct electricity to keep the heart beating have a previously unrecognized ability to regenerate in the days after birth, a new study in mice by University of Texas Southwestern researchers suggests.
TSUKUBA (JP), October 2021 — Mesenchymal stem cells (MSCs) are thought to have great potential in the field of regenerative medicine, which has the aim of restoring damaged tissues. However, not much was known about their in vivo plasticity – until now.